Report from the Annual General Meeting of EQL Pharma AB (publ) on August 27th, 2020
At EQL Pharma's Annual General Meeting, which was held in Lund, August 27[th], 2020, the following decisions were made:Adoption of the balance sheet and income statement, disposition regarding the Company’s results The annual general meeting resolved to adopt the balance sheet and income statement and the consolidated balance sheet and income statement for the financial year 2019-04-01 – 2020-03-31. The annual general meeting also resolved that no dividends shall be paid for the financial year 2019/2020. Discharge from liability for the Board of Directors and the Managing Director